GUWAHATI: The President of India, Droupadi Murmu, inaugurated India’s first home-grown gene therapy for cancer at the Indian Institute of Technology (IIT) Bombay, on April 4, 2024. Addressing the gathering, the President hailed the launch of India’s maiden gene therapy as a significant milestone in the fight against cancer.
Named "CAR-T cell therapy," this accessible and affordable treatment option offers renewed hope for patients battling cancer. President Murmu expressed confidence that the therapy would prove successful in providing a new lease of life for countless individuals.
Click here to join our WhatsApp channel
CAR-T cell therapy, the President noted, stands as one of the most remarkable breakthroughs in medical science. While previously available only in developed nations, its exorbitant costs rendered it inaccessible to the majority of patients worldwide.
However, President Murmu emphasised that the therapy being unveiled today marks a paradigm shift, being the world’s most affordable CAR-T cell therapy. She commended the collaborative efforts between IIT Bombay, Tata Memorial Hospital, and industry partner ImmunoACT in developing India’s first CAR-T cell therapy.
ALSO READ: Seminar To Analyse Various Aspects Of NEP 2020 Held At Gauhati University
This fruitful academia-industry partnership serves as an inspiring model for future endeavours, the President noted. The successful development of CAR-T cell therapy, she emphasised, epitomises the fusion of technology and healthcare, facilitated by partnerships between esteemed academic institutions and industry players.
